Response by Elliott et al to Letter Regarding Article, "Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy"

被引:1
|
作者
Elliott, Perry [1 ]
Gundapaneni, Balarama [2 ]
Sultan, Marla B. [3 ]
机构
[1] UCL, London, England
[2] Pfizer Inc, Groton, CT 06340 USA
[3] Pfizer Inc, New York, NY USA
关键词
D O I
10.1161/CIRCHEARTFAILURE.122.009637
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Beta-blocker exposure and long-term survival in patients with transthyretin amyloid cardiomyopathy
    Barge-Caballero, G.
    Barge Caballero, E.
    Lopez-Perez, M.
    Bilbao-Quesada, R.
    Gonzalez-Babarro, E.
    Gomez-Otero, I.
    Lopez-Lopez, A.
    Gutierrez-Feijoo, M.
    Varela-Roman, A.
    Gonzalez-Juanatey, C.
    Diaz-Castro, O.
    Crespo-Leiro, M.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1806 - 1806
  • [22] Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term extension studies
    Rozenbaum, Mark H.
    Garcia, Andrea
    Grima, Daniel
    Tran, Diana
    Bhambri, Rahul
    Stewart, Michelle
    Li, Benjamin
    Heeg, Bart
    Postma, Maarten
    Masri, Ahmad
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2022, 8 (05) : 529 - 538
  • [23] Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy
    Coelho, Teresa
    Maia, Luis F.
    da Silva, Ana Martins
    Cruz, Marcia W.
    Plante-Bordeneuve, Violaine
    Suhr, Ole B.
    Conceicao, Isabel
    Schmidt, Hartmut H. -J.
    Trigo, Pedro
    Kelly, Jeffery W.
    Labaudiniere, Richard
    Chan, Jason
    Packman, Jeff
    Grogan, Donna R.
    JOURNAL OF NEUROLOGY, 2013, 260 (11) : 2802 - 2814
  • [24] Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy
    Teresa Coelho
    Luis F. Maia
    Ana Martins da Silva
    Márcia W. Cruz
    Violaine Planté-Bordeneuve
    Ole B. Suhr
    Isabel Conceiçao
    Hartmut H.-J. Schmidt
    Pedro Trigo
    Jeffery W. Kelly
    Richard Labaudinière
    Jason Chan
    Jeff Packman
    Donna R. Grogan
    Journal of Neurology, 2013, 260 : 2802 - 2814
  • [25] Letter by Zhou et al Regarding Article, "Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease"
    Zhou, Xin
    Sun, Pengfei
    Yang, Qing
    CIRCULATION, 2023, 147 (16) : 1256 - 1257
  • [26] Letter by D'Anna et al Regarding Article, "Long-Term Mortality in Patients With Stroke of Undetermined Etiology"
    D'Anna, Lucio
    Janes, Francesco
    Gigli, Gian Luigi
    STROKE, 2013, 44 (01) : E3 - E3
  • [27] Letter by Dalzell et al Regarding Article, "Peripartum Cardiomyopathy"
    Dalzell, Jonathan R.
    Barton, Anna K.
    McKeag, Nicholas A.
    CIRCULATION, 2016, 134 (07) : E81 - E82
  • [28] Long- term tafamidis efficacy in patients with transthyretin amyloid cardiomyopathy by baseline left ventricular ejection fraction
    Drachman, Brian
    Damy, Thibaud
    Hanna, Mazen
    Wang, Rong
    Angeli, Franca S.
    Garcia-Pavia, Pablo
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S4 - S4
  • [29] Letter by Fornwalt et al Regarding Article, "Relationship of Echocardiographic Dyssynchrony to Long-Term Survival After Cardiac Resynchronization Therapy"
    Fornwalt, Brandon K.
    Leon, Angel R.
    Oshinski, John N.
    CIRCULATION, 2011, 124 (02) : E37 - E37
  • [30] Response by Nunez et al to Letter Regarding Article, "Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality"
    Nunez, Julio
    Nunez, Eduardo
    Sanchis, Juan
    Bayes-Genis, Antoni
    CIRCULATION, 2018, 138 (15) : 1613 - 1614